Prostate Cancer Clinical Trial
Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging
This is a two-tiered pilot study in which there will be no randomization and no placebo treatment. This study will be to perform metabolic magnetic resonance imaging on men suspected to have a prostate cancer to understand if metabolic MRI can be safely performed on this population
Age greater than 40 and less than 80 years
Clinical suspicion or history of prostate cancer reflected by one of the following:
PSA > 4ng/ml
Abnormal DRE exam
Known tissue diagnosis of prostate cancer from prior workup
Patient planning to undergo either a MRI targeted biopsy or radical prostatectomy for prostate cancer workup or treatment
Inability to undergo MRI scan
Inability to receive IV contrast as per institutional protocol.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.